PARAGARD T 380A: payments to doctors
Payments that named PARAGARD T 380A as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $494K
- Providers
- 10,704
- Transactions
- 17,906
- Average per transaction
- $28
The per-transaction average — $28 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 10,704 providers the average total is $46, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Coopersurgical, Inc. | $494,143 | 100.0% |